Archive - March 2019
Roche gets EU nod for much-expanded Hemlibra label
UK breast cancer patients win early access to Tecentriq/nab-paclitaxel
More Brexit chaos as government suffers more defeats
EC extends license for Roche/Chugai’s Hemlibra
The 2019 PharmaTimes Marketer of the Year competition opens its doors for entry
Novo Nordisk testing behavioural science to improve patient support
MSD highlight importance of digital transformation
Eating Mushrooms Could Slash Brain Decline Risk In Half